Introduction
Polyarteritis nodosa is a form of medium-vessel vasculitis, and its symptoms reflect injury to arteries that supply blood to organs, muscles, nerves, skin, and the digestive tract. The most common symptoms include fever, fatigue, weight loss, muscle and joint pain, skin changes such as painful nodules or livedo reticularis, nerve pain or weakness, abdominal pain, and signs of reduced blood flow to organs. These symptoms arise because inflammation damages arterial walls, narrows the vessel lumen, and can produce clots or aneurysms that interrupt circulation.
The disorder does not affect every tissue equally. Symptoms depend on which arteries are inflamed and how severely blood flow is reduced. In some people the disease produces a gradual, systemic illness marked by malaise and aching; in others it causes sudden ischemic injury in one organ system, such as the kidneys, intestines, or peripheral nerves. The pattern is therefore best understood as the clinical expression of segmental arterial inflammation and tissue hypoxia.
The Biological Processes Behind the Symptoms
Polyarteritis nodosa centers on inflammation of medium-sized muscular arteries. Immune-mediated injury targets the vessel wall, especially the muscular and elastic layers, leading to edema, cellular infiltration, and structural weakening. As the wall becomes inflamed, the arterial lumen can narrow from swelling and intimal thickening, while the weakened wall may bulge into microaneurysms. These two changes, narrowing and aneurysmal damage, are the main reasons symptoms appear so varied.
When an artery narrows, downstream tissue receives less oxygen and fewer nutrients. Cells switch to less efficient metabolism, producing pain, fatigue, and impaired function. When an artery occludes completely, infarction can occur. In tissues with little collateral circulation, even brief interruption of blood flow can produce severe symptoms. This explains why the kidneys, gastrointestinal tract, skin, and peripheral nerves are frequent sites of disease expression.
Inflammation also stimulates systemic immune signaling. Cytokines such as interleukins and tumor necrosis factor contribute to fever, loss of appetite, and the metabolic changes that promote weight loss and exhaustion. At the same time, damaged vessel walls can leak blood or become thrombosed, adding local tenderness, purpura, livedoid discoloration, or organ ischemia to the picture. The symptom profile of polyarteritis nodosa therefore reflects both local vascular obstruction and whole-body inflammatory activation.
Common Symptoms of Polyarteritis nodosa
Fever and malaise are among the earliest and most general symptoms. Fever may be low-grade or persistent, and malaise often feels like a vague but overwhelming sense of illness. These features arise from inflammatory cytokines acting on the hypothalamus and altering energy regulation. They are not specific to one organ, which is why they often precede more localized findings.
Fatigue and weight loss commonly develop as inflammation raises metabolic demand while suppressing appetite. Fatigue reflects both the systemic inflammatory state and reduced tissue oxygen delivery. Weight loss occurs because the body breaks down fat and muscle more rapidly, while appetite often falls. In a chronic vasculitic illness, this can become progressive and noticeable over weeks or months.
Muscle pain and myalgia usually affect the thighs, calves, or larger muscle groups. The discomfort is often deep and aching rather than superficial. It results from ischemia in small and medium arteries supplying skeletal muscle, along with inflammatory irritation of surrounding tissues. Joint pain can accompany this process and may be migratory or diffuse, though true destructive arthritis is less typical than pain without major joint damage.
Peripheral nerve symptoms are a defining feature in many cases. Patients may describe burning pain, tingling, numbness, or sudden weakness, often in a pattern known as mononeuritis multiplex, where separate nerves are affected in different locations. This occurs because vasculitis compromises the vasa nervorum, the small arteries that nourish peripheral nerves. Nerves are highly sensitive to ischemia, so even moderate vessel injury can produce prominent sensory and motor deficits.
Skin findings are another common clue. Livedo reticularis appears as a netlike, violaceous pattern, usually on the legs, and reflects uneven blood flow through inflamed cutaneous arteries. Painful subcutaneous nodules may form when medium vessels in the skin and subcutis become inflamed. Some people develop ulcers, tender spots, or areas of purpura when vessel damage causes local ischemia or leakage of blood into the skin. These changes often become more visible in dependent areas where circulation is already under higher stress.
Abdominal pain is common when mesenteric arteries are involved. The pain is often crampy, postprandial, or severe enough to suggest intestinal ischemia. The mechanism is straightforward: narrowed or obstructed vessels deprive the bowel of adequate perfusion, especially during digestion when oxygen demand rises. If ischemia becomes advanced, nausea, vomiting, and gastrointestinal bleeding can follow because the mucosa is particularly vulnerable to reduced blood flow.
Kidney-related symptoms usually involve hypertension rather than the urinary findings typical of many other kidney diseases. In polyarteritis nodosa, the renal arteries can become inflamed and narrowed, activating the renin-angiotensin system. This raises blood pressure and can worsen headache, visual disturbance, and cardiovascular strain. Kidney function may decline, but the glomeruli are usually spared compared with smaller-vessel vasculitides, so severe urinary sediment is less prominent than in some other inflammatory renal disorders.
How Symptoms May Develop or Progress
The illness often begins with nonspecific constitutional symptoms. Fever, fatigue, anorexia, and weight loss may appear before any clear organ-specific problem becomes obvious. This early phase corresponds to systemic inflammation, in which cytokine signaling has already intensified but vascular damage has not yet produced obvious ischemic injury in one location. Because the early symptoms are broad and common, the disease may initially seem like a nonspecific inflammatory syndrome.
As vascular injury accumulates, symptoms become more localized. Reduced perfusion to nerves may produce asymmetric weakness or numbness, and mesenteric involvement may lead to recurrent abdominal pain. Skin manifestations can emerge as the cutaneous circulation becomes compromised. In this stage, the symptom pattern becomes more heterogeneous because different arterial territories are affected at different times. Polyarteritis nodosa is classically segmental, meaning one part of an artery may be diseased while another segment is relatively spared, creating patchy and evolving symptoms.
Progression can also reflect the development of thrombosis, aneurysm formation, or complete occlusion. A vessel that is initially narrowed may later thrombose, abruptly worsening ischemia. Conversely, aneurysmal weakening may cause local pain or hemorrhagic complications. The fluctuating course in some patients comes from the fact that inflammation may wax and wane in one vascular bed while continuing in another. This produces symptom variability across days or weeks rather than a uniform steady decline.
When progression is more aggressive, symptoms can shift from constitutional complaints to signs of organ dysfunction. Severe abdominal pain, rapidly worsening neuropathy, uncontrolled hypertension, or evidence of kidney failure indicate that perfusion has dropped enough to impair organ performance. The underlying biology is the same throughout: inflammation of medium arteries leads to structural vessel injury, and organ symptoms appear when blood supply crosses a threshold below which tissue can no longer function normally.
Less Common or Secondary Symptoms
Some patients develop testicular pain or scrotal tenderness when the arteries supplying the gonads are involved. This symptom can be striking because the tissue is sensitive to ischemia and the pain may be unilateral. It reflects the same mechanism seen elsewhere: arterial inflammation limits blood flow to a tissue with high vascular dependence.
Headache, visual symptoms, or neurologic complaints may occur if cranial or cerebral vessels are affected, although the central nervous system is less commonly involved than peripheral nerves. Headache may result from hypertension, vascular inflammation, or secondary ischemia. Visual changes can reflect reduced perfusion or blood pressure surges that strain retinal circulation.
Some individuals experience cardiac symptoms such as chest discomfort, reduced exercise tolerance, or arrhythmia when coronary arteries are affected. While not the most common presentation, coronary involvement can produce ischemia in the myocardium, leading to pain or functional impairment. The mechanism is similar to that in the intestines or nerves: inflammation narrows the vessel and starves tissue of oxygen.
Edema may occur when renal dysfunction or vascular injury alters fluid balance. Swelling is usually secondary rather than a direct hallmark of the vasculitis itself. Likewise, nonspecific symptoms such as night sweats, depression, or concentration difficulties may appear as part of systemic inflammation or chronic pain, but they are less distinctive than the vascular and ischemic manifestations.
Factors That Influence Symptom Patterns
Symptom severity depends largely on which arteries are involved and how extensive the inflammation is. Limited disease affecting only one vascular territory may produce a small number of dominant symptoms, while more widespread involvement generates a multisystem pattern. Because the disease affects medium-sized arteries, the clinical picture is often determined by the distribution of blood supply rather than by uniform inflammation of an entire organ.
Age and overall health modify how symptoms are expressed. Older adults or people with preexisting vascular disease may experience worse tissue tolerance to reduced blood flow, so ischemic symptoms can appear sooner or more intensely. In contrast, younger patients may initially tolerate partial vascular narrowing but still develop prominent neuropathic or constitutional symptoms. Baseline organ reserve influences how far perfusion can fall before symptoms become obvious.
Environmental or physiologic stressors can amplify symptom expression by increasing tissue oxygen demand. For example, exertion may make muscle ischemia more noticeable, and meals may unmask abdominal pain if mesenteric blood flow is already compromised. Intercurrent infections or inflammatory stimuli can also intensify systemic cytokine activity, making fever, fatigue, and appetite loss more prominent. These factors do not create the disease, but they shape when and how the underlying vascular injury becomes clinically visible.
Related medical conditions can blur the pattern. Hypertension, diabetes, smoking-related vascular damage, or other inflammatory disorders may compound ischemic symptoms or make them less specific. The symptom pattern then reflects overlapping mechanisms: intrinsic arterial inflammation from polyarteritis nodosa combined with reduced vascular reserve from other conditions. This can make organ symptoms appear earlier or make recovery from ischemic episodes less complete.
Warning Signs or Concerning Symptoms
Certain symptoms suggest that vascular injury is producing significant organ compromise. Severe abdominal pain, especially if it is sudden, persistent, or associated with vomiting or blood in the stool, may indicate mesenteric ischemia or bowel infarction. These findings arise when inflamed arteries can no longer provide enough perfusion to the intestine, leading to tissue injury that can progress rapidly.
New weakness, foot drop, or asymmetric numbness can signal worsening nerve ischemia. In mononeuritis multiplex, the affected nerve loses function because its blood supply has been disrupted. Progressive motor deficits are concerning because they indicate ongoing injury to the nerve itself rather than transient irritation.
Marked hypertension, headache, or reduced urine output may indicate renal artery involvement severe enough to activate hormonal blood pressure pathways or compromise renal perfusion. If kidney ischemia advances, the body may retain sodium and water, further worsening pressure and organ strain. Very high blood pressure can in turn damage small vessels in the brain, eyes, and heart.
Chest pain, shortness of breath, or syncope are concerning because they may reflect myocardial ischemia or major circulatory compromise. When coronary blood flow drops, the heart muscle becomes electrically unstable and mechanically less efficient. These symptoms point to significant vascular involvement and a higher risk of acute complications.
Skin ulcers, rapidly spreading discoloration, or areas of necrosis suggest that cutaneous blood supply has fallen below the level needed to sustain tissue viability. They represent a more advanced stage of vascular damage in which ischemia is no longer limited to pain or color change but has progressed to cell death.
Conclusion
The symptoms of polyarteritis nodosa are the direct clinical result of inflammation in medium-sized arteries. Fever, fatigue, and weight loss reflect systemic immune activation. Painful skin changes, neuropathy, abdominal pain, and hypertension arise when vessel injury narrows blood flow or causes thrombosis and ischemia in specific organs. The disease often begins with broad constitutional symptoms and then evolves into a more localized pattern as different arterial beds become involved.
Understanding the symptom pattern depends on understanding the biology: inflamed arteries cannot reliably deliver oxygen and nutrients, and the tissues they supply respond with pain, dysfunction, or injury. Polyarteritis nodosa is therefore not a single-symptom condition but a vascular process whose manifestations vary according to the arteries affected and the degree of perfusion loss.